Danske Bank A/S Penumbra Inc Transaction History

Danske Bank A/S

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 19, 2025	BUY	$227.15 - $287.09 $68,145 - $86,126	300 New	300 $75,000
Q2 2025 Dec 18, 2025	SELL	$253.22 - $299.78 $2.04 Million - $2.41 Million	-8,037 Reduced 96.04%	331 $84,000
Q1 2025 Dec 18, 2025	BUY	$237.28 - $303.76 $1.91 Million - $2.45 Million	8,068 Added 2689.33%	8,368 $2.24 Million

475

30.6M

309K

95.9K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $10.6B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Danske Bank A/S, based on Form 13F filings with the SEC.

Stay updated on Danske Bank A/S with notifications on news.